Approach guide for patient orientation for adherence to pharmacotherapy in heart failure
DOI:
https://doi.org/10.33448/rsd-v10i15.22899Keywords:
Pharmaceutical Services; Medication adherence; Heart failure/therapy; Drug Utilization; Community pharmacy services.Abstract
Objective: to develop a quick and easy consultation tool to standardize the conduct of different members of the care team for pharmaceutical guidance and promotion of adherence to pharmacotherapy in heart failure (HF). Method: experimental development study that consisted of bringing together the authors' experience and recommendations published in technical and scientific publications for the development of an instrument to support the pharmaceutical guidance approach and promotion of adherence of patients with HF. Development: the Guide was organized in the form of a table that lists the type of approach according to the patients' responses to the Morisky-Green Test (TMG) items, considering the intentional and unintentional factors that interfere with the adherence behavior, reconciling the approach of the 4 items of the TMG to the approach of 16 reasons for non-adherence by Culig. A third set of factors was also added, which are those related to medications. Conclusion: the Guide was developed and applied, proving to be a useful tool to streamline and standardize the conduct during the pharmacotherapeutic follow-up to patients with HF, contributing to better results in interventions to promote adherence.
References
Albuquerque, D. C., Souza Neto, J. D., Bacal, F., Rohde, L. E., Bernardez-Pereira, S., Berwanger, O., & Almeida, D. R. (2015). I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes. Arq Bras Cardiol, 104(6), 433–442. https://doi.org/10.5935/abc.20150031
Barretto, A. C. P., del Carlo, C. H., Cardoso, J. N., Morgado, P. C., Munhoz, R. T., Eid, M. O., Oliveira Jr, M. T., Scipioni, A. R., & Ramires, J. A. F. (2008). Re-hospitalizações e morte por insuficiência cardíaca - Índices ainda alarmantes / Hospital readmissions and death from heart failure - Rates still alarming. Arquivos Brasileiros de Cardiologia, 91(5), 309–341. https://doi.org/10.1590/S0066-782X2008001700009
Bocchi, E. A., Braga, F. G. M., Ferreira, S. M. A., Rohde, L. E. P., Oliveira, W. A. de, Almeida, D. R. de, Moreira, M. da C. V., Bestetti, R. B., Bordignon, S., Azevedo, C., Tinoco, E. M., Rocha, R. M., Issa, V. S., Ferraz, A., Cruz, F. das D., Guimarães, G. V., Montera, V. dos S. P., Albuquerque, D. C., Bacal, F., … Montera, M. W. (2009). III Diretriz Brasileira de Insuficiência Cardíaca Crônica. Arquivos Brasileiros de Cardiologia, 93, 3–70.
Brasil, M. da S. (2010). Formulário terapêutico nacional 2010: Rename 2010. http://www.saude.gov.br/bvs
Brasil, M. da S. (2015). Relação Nacional de Medicamentos Essenciais : RENAME 2014 (Ministério da Saúde, Ed.; 9th ed.). Ministério da Saúde. www.saude.gov.br/medicamentos
Camuzi, R. C. (2017). Adesão de pacientes com insuficiência cardíaca à farmacoterapia: as experiências de dois centros clínicos especializados. https://doi.org/10.13140/RG.2.2.28686.72007
Camuzi, R. C., Cordeiro, B. C., Elias, S. C., Martins, W. de A., Mesquita, E. T., & Castilho, S. R. de. (2016). Perfil de utilização e adesão ao tratamento medicamentoso por pacientes atendidos em Clínica de Insuficiência Cardíaca de um Hospital Universitário da Região Metropolitana do Rio de Janeiro. Rev Bras Farm, 97(Sup), 61–77.
Camuzi, R. C., Moraes, J. R. de, Oliveira, E. B. de, Peixoto, R. T., Mesquita, E. T., & Castilho, S. R. de. (2021). Adesão farmacoterapêutica em insuficiência cardíaca: estudo exploratório num centro especializado fluminense. Brazilian Journal of Health Review, 4(6). No prelo.
CNPq. (2021). Glossário - Plataforma Lattes - CNPq. Glossário. http://lattes.cnpq.br/web/dgp/glossario?p_p_id=54_INSTANCE_QoMcDQ9EVoSc&_54_INSTANCE_QoMcDQ9EVoSc_struts_action=%2Fwiki_display%2Fview&_54_INSTANCE_QoMcDQ9EVoSc_nodeName=Main&_54_INSTANCE_QoMcDQ9EVoSc_title=Pesquisa
Culig, J., Leppee, M., Boskovic, J., & Eric, M. (2011). Determining the difference in medication compliance between the general patient population and patients receiving antihypertensive therapy: a case study. Archives of Pharmacal Research, 34(7), 1143–1152. https://doi.org/10.1007/s12272-011-0712-0
Davis, E. M., Packard, K. A., & Jackevicius, C. A. (2014). The Pharmacist Role in Predicting and Improving Medication Adherence in Heart Failure Patients. Journal of Managed Care Pharmacy, 20(7), 741–755. https://doi.org/10.18553/jmcp.2014.20.7.741
Despaigne, R. M., Sanchez, C. M. D., & Sarfraz, A. (2012). Therapeutic adherence in outpatients with heart failure registered with a community pharmacy. Braz. J. Pharm. Sci., 48(1), 61–68. http://dx.doi.org/10.1590/S1984-82502012000100007
Fitzgerald, A. A., Powers, J. D., Ho, P., Maddox, T. M., Peterson, P., Allen, L., Masoudi, F. A., Magid, D., & Havranek, E. (2011). Impact of Medication Nonadherence on Hospitalizations and Mortality in Heart Failure. J. Card. Fail., 17(8), 664–669. https://doi.org/10.1016/j.cardfail.2011.04.011
Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14(1), 1–24.
Jackevicius, C. A. a b d f, Li, P. e, & Tu, J. V. b c e. (2008). Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation, 117(8), 1028–1036. https://doi.org/10.1161/CIRCULATIONAHA.107.706820
Jessup, M. (2014). The Heart Failure Paradox: An Epidemic of Scientific Success: Presidential Address at the American Heart Association 2013 Scientific Sessions. Circulation, 129(25), 2717–2722. https://doi.org/10.1161/CIR.0000000000000065
Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009). Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 12(6), 989–995. https://doi.org/10.1111/j.1524-4733.2009.00543.x
López Cabezas, C. a e f, Falces Salvador, C. b g, Cubí Quadrada, D. a f, Arnau Bartés, A. c h, Ylla Boré, M. a f, Muro Perea, N. d i, & Homs Peipoch, E. a f. (2006). Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure [Ensayo clínico aleatorizado de un programa de atención farmacéutica al alta frente a seguimiento habitual en pacientes con ins. Farmacia Hospitalaria, 30(6), 328–342. https://doi.org/10.1016/S1130-6343(06)74004-1
Lowry, K. P., Dudley, T. K., Oddone, E. Z., & Bosworth, H. B. (2005). Intentional and unintentional nonadherence to antihypertensive medication. The Annals of Pharmacotherapy, 39(7–8), 1198–1203. https://doi.org/10.1345/aph.1E594
Mangini, S., Silveira, F. S., Silva, C. P., Grativvol, P. S., Seguro, L. F. B. da C., Ferreira, S. M. A., Mocelin, A. O., Cardoso, L. F., Bacal, F., & Bocchi, E. A. (2008). Decompensated heart failure in the emergency department of a cardiology hospital. Arquivos Brasileiros de Cardiologia, 90(6), 433–440.
Marinker, M., & Shaw, J. (2003). Not to be taken as directed. BMJ, 326(7385), 348–349.
Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74. http://www.ncbi.nlm.nih.gov/pubmed/3945130
Morley, P. C., Strand, L. M., & Cipolle, R. J. (2004). Pharmaceutical Care Practice: The Clinician’s Guide.
Náfrádi, L., Galimberti, E., Nakamoto, K., & Schulz, P. J. (2016). Intentional and Unintentional Medication Non-Adherence in Hypertension: The Role of Health Literacy, Empowerment and Medication Beliefs. Journal of Public Health Research, 5(3), 762. https://doi.org/10.4081/jphr.2016.762
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R. A., Jedraszewski, D., Cotoi, C., & Haynes, R. B. (2014). Interventions for enhancing medication adherence. Cochrane Database Syst Rev, 11, CD000011. https://doi.org/10.1002/14651858.CD000011.pub4
Oliveira-Filho, A. D., Morisky, D. E., Costa, F. A., Pacheco, S. T., Neves, S. F., & Lyra-Jr, D. P. (2014). Improving post-discharge medication adherence in patients with CVD: a pilot randomized trial. Arq Bras Cardiol, 103(6), 503–512. https://doi.org/10.5935/abc.20140151
Roger, V. L. (2013). Epidemiology of Heart Failure. Circulation Research, 113(6), 646–659.
Rohde, L. E. P., Montera, M. W., Bocchi, E. A., Clausell, N. O., Albuquerque, D. C. de, Rassi, S., Colafranceschi, A. S., Freitas Junior, A. F. de, Ferraz, A. S., Biolo, A., Barretto, A. C. P., Ribeiro, A. L. P., Polanczyk, C. A., Gualandro, D. M., Almeida, D. R., Silva, E. R. R. da, Figueiredo, E. L., Mesquita, E. T., Marcondes-Braga, F. G., … Martins, W. de A. (2018). Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda. Arquivos brasileiros de cardiologia, 111(3), 436–539.
van der Wal, M. H. L., & Jaarsma, T. (2008). Adherence in heart failure in the elderly: Problem and possible solutions. International Journal of Cardiology, 125(2), 203–208. https://doi.org/10.1016/j.ijcard.2007.10.011
WHO, W. H. O. (2003). Adherence to long-term therapies: evidence for action. World Health Organization. http://www.who.int/chp/knowledge/publications/adherence_introduction.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ranieri Carvalho Camuzi; Jéssica Quintanilha Marcelo de Carvalho; Rafaela Tavares Peixoto; Evani Leite de Freitas; Evandro Tinoco Mesquita; Selma Rodrigues de Castilho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
